ArticleJournal of advanced research2025

20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters.

Yulin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.